NCT04303325View on ClinicalTrials.gov

Effect of Esketamine on Postoperative Depression、Gut Microbiota、Bispectral Index Data of Depression Patients Undergoing Breast Cancer Operation (ESPOD-BI)

PHASE4RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

October 8, 2021

Primary Completion Date

October 30, 2024

Study Completion Date

December 30, 2024

Conditions
Depression
Interventions
DRUG

Esketamine

All depression patients undergoing breast cancer operation will be to the treatment intervention with general anesthesia as an adjunct to esketamine 0.2mg/kg.

DRUG

Saline Solution

All depression patients undergoing breast cancer operation will be to the treatment intervention with general anesthesia as an adjunct to saline.

Trial Locations (1)

110001

RECRUITING

the First Hospital of China Medical University, Shenyang

All Listed Sponsors
lead

China Medical University, China

OTHER